Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease

  title={Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease},
  author={George J. Brewer},
  • G. Brewer
  • Published 1 March 2012
  • Biology
  • BioFactors
In this special issue about biofactors causing cognitive impairment, we present evidence for and discuss two such biofactors. One is excess copper, causing neuronal toxicity. The other is zinc deficiency, causing neuronal damage. We present evidence that Alzheimer's disease (AD) has become an epidemic in developed, but not undeveloped, countries and that the epidemic is a new disease phenomenon, beginning in the early 1900s and exploding in the last 50 years. This leads to the conclusion that… 

Alzheimer’s disease causation by copper toxicity and treatment with zinc

The inorganic copper hypothesis fits well with the Squitti group data, and it is postulate that the new emerging environmental factor partially causal of the AD epidemic is ingestion of inorganic Copper from drinking water and taking supplement pills, along with a high fat diet.

Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches

A better understanding of Cu ions’ current status in several AD features is presented, and a short review of the modern therapeutic approach in chelation therapy, with the main focus on Cu ions is discussed.

Disruption of zinc homeostasis and the pathogenesis of senile dementia.

Zn acts as a contributor to Alzheimer's disease in the oligomerization, and as a protector in the neurotoxicity of Alzheimer's β-amyloid protein, and the possible role of carnosine (β-alanyl histidine) as a protective substance for neuronal injury is discussed.

Avoiding Alzheimer’s disease: The important causative role of divalent copper ingestion

  • G. Brewer
  • Biology
    Experimental biology and medicine
  • 2019
The author hypothesizes that the environmental change causing the epidemic of Alzheimer’s disease is ingestion of divalent copper, based on data indicating that food copper is primarily monovalent copper, and humans evolved safe ways of channeling monovalENT copper, but not divalent Copper.

Copper in Brain and Neurodegeneration

Therapeutic outcomes, together with improved resolution of techniques for identifying Cu distribution in brain cells, are providing valuable new insights into the role of Cu in neuronal and glial cell homeostasis.

Role of Copper in the Onset of Alzheimer’s Disease Compared to Other Metals

The involvement of copper in AD is controversial, as some studies show a copper deficiency in AD, and consequently a need to enhance copper levels, while other data point to copper overload and therefore a needs to reduce copper levels.



Treatment of Alzheimer's disease by zinc compounds

At the onset of Alzheimer's disease (AD), specific lesions occur in the hippocampus, i.e., neuropile‐capillary amyloid (AM) plaques and neuronal paired‐helical filaments (PHF)‐neurofibrillary tangles

Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease

  • D. SparksB. Schreurs
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 2003
It is shown that the addition of trace amounts of copper to water given to cholesterol-fed rabbits can induce β-amyloid accumulation, including senile plaque-like structures in the hippocampus and temporal lobe, and can significantly retard the ability of rabbits to learn a difficult trace conditioning task.

Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology.

Water quality may have a significant influence on disease progression and Ab neuropathology in AD as well as administration of distilled water, which produced a reduction in the expected accumulation of Ab in three separate animal models.

Serum zinc is decreased in Alzheimer’s disease and serum arsenic correlates positively with cognitive ability

Arsenic positively correlated with Mini-Mental State Examination score and the arsenic correlation might be caused by the major contribution of seafood consumption to intake of both arsenic and docosahexaenoic acid, of which the latter may delay AD.

Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction

The data support the idea that controlling the brain Zn2+ homeostasis may be beneficial in the treatment of AD.

Treatment of Wilson's disease with zinc: XV long-term follow-up studies.

Contrasting, Species-Dependent Modulation of Copper-Mediated Neurotoxicity by the Alzheimer's Disease Amyloid Precursor Protein

It is demonstrated for the first time that Cu-metallated full-length APP ectodomain induces neuronal cell death in vitro and suggests that targeting of inhibitors to histidine residues at positions 147 and 151 of APP could significantly alter the oxidative potential of APP.

Is cognitive function linked to serum free copper levels? A cohort study in a normal population

The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I)

Copper ion-mediated toxicity may contribute to neurodegeneration in Alzheimer's disease.

Subclinical Zinc Deficiency in Alzheimer’s Disease and Parkinson’s Disease

Results showed a significantly lower blood zinc in patients with Alzheimer’s and patients with Parkinson's disease than in controls, and these patients are probably zinc deficient because of nutritional inadequacy.